139 related articles for article (PubMed ID: 1695268)
1. [The effect of histamine H2 receptor blockaders on the proteolytic activity in patients with ulcers].
Bashir BM
Lab Delo; 1990; (4):25-7. PubMed ID: 1695268
[TBL] [Abstract][Full Text] [Related]
2. [Action of histamine H2 receptor blockaders on gastric motor function in duodenal peptic ulcer].
Shcherbak VV; Glubochenko VG; Zaĭdman VE
Klin Med (Mosk); 1984 Jun; 62(6):94-6. PubMed ID: 6147438
[No Abstract] [Full Text] [Related]
3. Histamine-2-receptor blocker cimetidine in African patients with duodenal ulceration--a preliminary communication.
Wasunna JB
East Afr Med J; 1979 Jan; 56(1):42-4. PubMed ID: 35333
[No Abstract] [Full Text] [Related]
4. [Therapy of duodenal ulcer with H2-blockers. 2 x 150 mg ranitidine versus 2 x 400 mg cimetidine].
Hüttemann W
Fortschr Med; 1983 Jan; 101(4):139-41. PubMed ID: 6131857
[TBL] [Abstract][Full Text] [Related]
5. Famotidine in the treatment of duodenal ulcers resistant to other histamine H2-receptor antagonists.
Chen PH; Wang TH; Wang CY; Chen CY; Cheng TC; Tsai YT; Siauw CP; Yang KC; Chen GH; Sung JL
J Int Med Res; 1989; 17 Suppl 1():25A-31A. PubMed ID: 2566541
[TBL] [Abstract][Full Text] [Related]
6. The histological maturity of regenerating mucosa of healed duodenal ulcer and ulcer recurrence after treatment with H2-antagonist.
Pan S; Liao CH
Am J Gastroenterol; 1990 Aug; 85(8):949-52. PubMed ID: 1973870
[TBL] [Abstract][Full Text] [Related]
7. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
8. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
Hentschel E
Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
[No Abstract] [Full Text] [Related]
9. New H2-receptor antagonist--roxatidine acetate--in treatment of duodenal ulcer.
Amarapurkar DN; Parikh SS; Desai HG
J Assoc Physicians India; 1993 Aug; 41(8):496-7. PubMed ID: 7904993
[TBL] [Abstract][Full Text] [Related]
10. A comparison of nizatidine with the three other histamine receptor antagonists for duodenal ulcer therapy.
Lima M; Holdcroft C
Nurse Pract; 1989 Feb; 14(2):41-2. PubMed ID: 2564655
[TBL] [Abstract][Full Text] [Related]
11. [Effects of cimetidine, a H2-histamine blocker, on ulcer cicatrization processes in patients with peptic ulcer localized in the duodenal bulb].
Belousov AS; Leont'eva GV; Rakitskaia LG; Kolesova OE; Lebkova NP; Akhmad Khzhuzh
Klin Med (Mosk); 1990 Mar; 68(3):96-9. PubMed ID: 2370765
[No Abstract] [Full Text] [Related]
12. Histamine-2 receptor antagonists.
Kumar P; Yachha SK; Misra S; Mehta S
Indian Pediatr; 1992 Aug; 29(8):1019-23. PubMed ID: 1360945
[No Abstract] [Full Text] [Related]
13. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
Thomas JM; Misiewicz G
Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
[No Abstract] [Full Text] [Related]
14. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
[TBL] [Abstract][Full Text] [Related]
15. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
Bardhan KD
Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
[TBL] [Abstract][Full Text] [Related]
16. Response to "H2-receptor antagonists and duodenal ulcer recurrence".
Kurata JH; Nogawa AN; Koch GG
Am J Gastroenterol; 1988 Dec; 83(12):1427-9. PubMed ID: 2904219
[No Abstract] [Full Text] [Related]
17. Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Nizatidine Multicenter Duodenal Ulcer Study Group.
Cherner JA; Cloud ML; Offen WW; Latz JE
Am J Gastroenterol; 1989 Jul; 84(7):769-74. PubMed ID: 2568086
[TBL] [Abstract][Full Text] [Related]
18. [Clinical, secretory, radiological and endoscopic evolution of patients with gastroduodenal ulcer treated with Ulcosilvanil, as compared with those treated with histamine H2 receptor antagonists].
Contraşiu P; Calinici V
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(4):359-63. PubMed ID: 6113650
[No Abstract] [Full Text] [Related]
19. [Anomalies in gastric stump emptying of patients who have undergone resections for duodenal ulcer previously treated with histamine H2 receptor antagonists].
Quaranta L; Segre D; Abbo L; Balestrino E; Clerico D; Emmolo I; Cardona R; Massimino S
Minerva Chir; 1989 May; 44(10):1475-8. PubMed ID: 2570381
[TBL] [Abstract][Full Text] [Related]
20. [The place of histamine H2 receptor antagonists in the treatment of diseases of the gastrointestinal tract].
Visnovský P; Valentík M
Cesk Gastroenterol Vyz; 1979 Jul; 33(5):312-5. PubMed ID: 41642
[No Abstract] [Full Text] [Related]
[Next] [New Search]
